OBJECTIVES: This study sought to assess the performance, effectiveness, and costs of a decentralized antenatal syphilis screening program in Nairobi, Kenya. METHODS: Health clinic data, quality control data, and costs were analyzed. RESULTS: The rapid plasma reagin (RPR) seroprevalence was 3.4%. In terms of screening, treatment, and partner notification, the program's performance was adequate. The program's effectiveness was problematic because of false-negative and false-positive RPR results. The cost per averted case was calculated to be US$95 to US$112. CONCLUSIONS: The sustainability of this labor-intensive program is threatened by costs and logistic constraints. Alternative strategies, such as the mass epidemiologic treatment of pregnant women in high-prevalence areas, should be considered.
OBJECTIVES: This study sought to assess the performance, effectiveness, and costs of a decentralized antenatal syphilis screening program in Nairobi, Kenya. METHODS: Health clinic data, quality control data, and costs were analyzed. RESULTS: The rapid plasma reagin (RPR) seroprevalence was 3.4%. In terms of screening, treatment, and partner notification, the program's performance was adequate. The program's effectiveness was problematic because of false-negative and false-positive RPR results. The cost per averted case was calculated to be US$95 to US$112. CONCLUSIONS: The sustainability of this labor-intensive program is threatened by costs and logistic constraints. Alternative strategies, such as the mass epidemiologic treatment of pregnant women in high-prevalence areas, should be considered.
Authors: M Temmerman; K Fonck; F Bashir; I Inion; J O Ndinya-Achola; J Bwayo; P Kirui; P Claeys; L Fransen Journal: Int J STD AIDS Date: 1999-06 Impact factor: 1.359
Authors: P Gichangi; K Fonck; C Sekande-Kigondu; J Ndinya-Achola; J Bwayo; D Kiragu; P Claeys; M Temmerman Journal: Int J STD AIDS Date: 2000-04 Impact factor: 1.359
Authors: K Fonck; N Kidula; W Jaoko; B Estambale; P Claeys; J Ndinya-Achola; P Kirui; J Bwayo; M Temmerman Journal: Sex Transm Infect Date: 2000-02 Impact factor: 3.519
Authors: M Temmerman; F A Plummer; N B Mirza; J O Ndinya-Achola; I A Wamola; N Nagelkerke; R C Brunham; P Piot Journal: AIDS Date: 1990-11 Impact factor: 4.177
Authors: J Newell; K Senkoro; F Mosha; H Grosskurth; A Nicoll; L Barongo; M Borgdorff; A Klokke; J Changalucha; J Killewo Journal: Genitourin Med Date: 1993-12
Authors: Gabriela B Gomez; Mary L Kamb; Lori M Newman; Jennifer Mark; Nathalie Broutet; Sarah J Hawkes Journal: Bull World Health Organ Date: 2013-01-17 Impact factor: 9.408
Authors: F Terris-Prestholt; D Watson-Jones; K Mugeye; L Kumaranayake; L Ndeki; H Weiss; J Changalucha; J Todd; F Lisekie; B Gumodoka; D Mabey; R Hayes Journal: Sex Transm Infect Date: 2003-10 Impact factor: 3.519
Authors: P Vickerman; R W Peeling; F Terris-Prestholt; J Changalucha; D Mabey; D Watson-Jones; C Watts Journal: Sex Transm Infect Date: 2006-12 Impact factor: 3.519
Authors: Pieter W Smit; David Mabey; John Changalucha; Julius Mngara; Benjamin Clark; Aura Andreasen; Jim Todd; Mark Urassa; Basia Zaba; Rosanna W Peeling Journal: PLoS One Date: 2013-09-16 Impact factor: 3.240